Quantcast

Latest organ transplants Stories

2014-03-30 23:02:50

Dr. Brett Bolton, founder and medical director at Great Hair Transplants has announced plans to offer a first ever MAXHARVEST™ live surgery workshop. The workshop, which will be held in the latter part of 2014, is being held to provide MAXHARVEST™ training to hair transplants surgeons around the world looking to provide patients with a better solution for hair loss. Brentwood, TN (PRWEB) March 30, 2014 The hair transplant industry is constantly looking for new and innovative ways to...

2014-03-26 10:48:12

Among veterans meeting eligibility for liver transplantation, greater distance from a Veterans Affairs transplant center or any transplant center was associated with lower likelihood of being put on a waitlist or receiving a transplant, and a greater likelihood of death, according to a study in the March 26 issue of JAMA. Centralization of specialized health care services is used to control costs, concentrate expertise, and minimize regional differences in quality of care. Although...

2014-03-26 10:44:42

Findings reveal system of centralized transplantation care may place lives at risk Veterans with liver disease who live more than 100 miles from a Veterans Administration hospital that offers liver transplants are only half as likely to be placed on the liver transplant waitlist to receive a new organ compared to veterans who live closer to transplant centers, according to a new study from the Perelman School of Medicine of the University of Pennsylvania. The findings, which are published...

2014-03-19 23:26:37

Hepatitis B Foundation honors liver transplant pioneer with highest scientific honor. Doylestown, PA (PRWEB) March 19, 2014 The Hepatitis B Foundation (http://www.hepb.org) is pleased to announce that it has selected Thomas E. Starzl, M.D., Ph.D., to receive its 2014 Baruch S. Blumberg Prize, the highest scientific honor that it confers. The Pennsylvania-based foundation is the only national nonprofit organization solely dedicated to finding a cure for hepatitis B. The board of directors...

2014-03-18 08:31:41

SynCardia Systems, Inc. Continues to Make Progress for Approval of the SynCardia Heart for Permanent Use to Save Patients Who Are Unlikely to Receive Another Donor Heart TUCSON, Ariz., March 18, 2014 /PRNewswire/ -- SynCardia Systems, Inc. is moving forward to gain FDA approval to use the SynCardia temporary Total Artificial Heart as destination therapy (a permanent replacement heart), which could save patients whose donor heart transplant is failing and are unlikely to receive another...

2014-03-18 08:26:31

LONDON, March 18, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:Liver Transplantation Global Clinical Trials Review, H2, 2013 Liver Transplantation Global Clinical Trials Review, H2, 2013SummaryGlobalData's clinical trial report, "Liver Transplantation Global Clinical Trials Review, H2, 2013" provides data on the Liver Transplantation clinical trial scenario. This report provides elemental information and data relating to the clinical trials on...

2014-03-15 08:21:40

In the news release, U.S. FDA Accepts Veloxis' New Drug Application for Envarsus® for the Prevention of Organ Rejection in Kidney Transplant Patients, issued 13-Mar-2014 by Veloxis Pharmaceuticals, we are advised that the first bullet should read "FDA has set a target review date under the Prescription Drug User Fee Act (PDUFA) of October 30, 2014" rather than "October 3, 2014" as originally issued inadvertently. The complete, corrected release follows: U.S. FDA Accepts Veloxis' New Drug...

2014-03-13 23:02:44

Lyfebulb Founder Dr. Hehenberger Reflects On Her Own Kidney Transplant And Encourages Other At-Risk Individuals to be Tested New York, NY (PRWEB) March 13, 2014 In commemoration of World Kidney Day, Dr. Karin Hehenberger and Lyfebulb, a life sciences and living empowerment platform that strives to educate, inspire, and finance cures so individuals with diabetes and other chronic conditions can lead better lives, join the global community to recognize the more than 20 million Americans...

2014-03-13 16:27:23

Decision Alleviates Concerns Over Potential for Organ Rejections, Preserves Physician Discretion Over Patient Care WASHINGTON, March 13, 2014 /PRNewswire-USNewswire/ -- Kidney Care Partners (KCP) voiced strong support for Centers for Medicare & Medicaid Services (CMS) Administrator Marilyn Tavenner's announcement that CMS would not finalize proposals to lift the protected class definition on three drug classes, including life-sustaining immunosuppressive drugs, that transplant...

2014-03-13 16:27:19

HORSHOLM, Denmark, March 13, 2014 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) today announced the U.S. FDA accepted for standard review the company's New Drug Application (NDA) for Envarsus(®) for the prevention of organ rejection in adult kidney transplant patients. Envarsus(®) is Veloxis' once-daily tacrolimus based on the company's proprietary MELTDOSE technology. Key points: -- FDA has set a target review date under the Prescription Drug User Fee Act (PDUFA)...


Word of the Day
baudekin
  • A rich embroidered or brocaded silk fabric woven originally with a warp of gold thread.
'Baudekin' seems to be an alternative form of 'baldachin,' from the Italian 'Baldacco,' Baghdad, the city where the material was made.
Related